Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOX1 | Q9Y5S8 | 11/20 | 0.41 |
| ▸ | GAA | P10253 | 6/20 | 0.41 |
| ▸ | MAPT | P10636 | 6/20 | 0.41 |
| ▸ | MEN1 | O00255 | 4/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.41 |
| ▸ | BCHE | P06276 | 2/20 | 0.41 |
| ▸ | ACHE | P22303 | 2/20 | 0.41 |
| ▸ | SNCA | P37840 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29281324 | 0.93 | NOX1 (0.42) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL5570560 | 0.90 | NOX1 (0.41) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL719307 | 0.83 | NOX1 (0.37) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL44485 | 0.81 | NOX1 (0.46) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL29421160 | 0.81 | NOX1 (0.46) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL5613287 | 0.80 | NOX1 (0.39) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL9932693 | 0.75 | NOX1 (0.53) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL3760150 | 0.73 | NOX1 (0.43) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL2211992 | 0.71 | NOX1 (0.41) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL1718554 | 0.70 | NOX1 (0.54) | NOX1GAAMAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11795414-B2 | Metalworking fluid containing a branched alcohol propoxylate | BASF SE | 2023-10-24 | — | — | US | disclosed |
| US-20220162514-A1 | METALWORKING FLUID CONTAINING A BRANCHED ALCOHOL PROPOXYLATE | BASF SE (DE) | 2022-05-26 | — | — | US | disclosed |
| EP-3953441-A1 | METALWORKING FLUID CONTAINING A BRANCHED ALCOHOL PROPOXYLATE | BASF SE (DE) | 2022-02-16 | — | — | EP | disclosed |
| US-11161813-B2 | Sterically hindered amines | BASF SE (DE) | 2021-11-02 | — | — | US | disclosed |
| WO-2020207881-A1 | METALWORKING FLUID CONTAINING A BRANCHED ALCOHOL PROPOXYLATE | BASF SE (DE) | 2020-10-15 | — | — | WO | disclosed |
| US-20200123107-A1 | STERICALLY HINDERED AMINES | BASF SE (DE) | 2020-04-23 | — | — | US | disclosed |
| EP-1730101-B1 | ALKYLATED PANA AND DPA COMPOSITIONS | BASF SE (DE) | 2015-11-18 | — | — | EP | disclosed |
| US-9181481-B2 | Liquid crystal display device and method of manufacturing the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-11-10 | — | — | US | disclosed |
| US-20150138493-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND METHOD OF MANUFACTURING THE SAME | SAMSUNG DISPLAY CO LTD (KR) | 2015-05-21 | — | — | US | disclosed |
| US-20120051965-A1 | N-ACYLSARCOSINE COMPOSITIONS | BASF SE (DE) | 2012-03-01 | — | — | US | disclosed |
| US-6468958-B2 | LIGHT, OXYGEN AND HEAT RESISTANCE | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-10-22 | — | — | US | disclosed |
| EP-0815089-B1 | BIPHENYL-SUBSTITUTED TRIAZINES AS LIGHT STABILIZER | CIBA SC HOLDING AG (CH) | 2002-09-25 | — | — | EP | disclosed |
| EP-1213283-A2 | Biphenyl-substituted triazines as light stabilisers | Ciba SC Holding AG (CH) | 2002-06-12 | — | — | EP | disclosed |
| US-6403680-B1 | PHOTO, HEAT, OXIDATION STABILIZERS | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-06-11 | — | — | US | disclosed |
| US-6365653-B1 | SUITABLE AS COLOUR-STABLE AND NONSTAINING STABILIZERS AND ANTIOZONANTS FOR PROTECTING NONBLACK ELASTOMERS AGAINST OXIDATIVE, THERMAL, LIGHT- OR OZONE-INDUCED DEGRADATION | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-04-02 | — | — | US | disclosed |
| US-20020016266-A1 | Lubricant compositions comprising thiophosphoric acid esters and dithiophosphoric acid esters | FLETSCHINGER MICHAEL (DE) | 2002-02-07 | — | — | US | disclosed |
| US-20010039341-A1 | Biphenyl-Substituted Triazines | FLETCHER IAN JOHN (CH) | 2001-11-08 | — | — | US | disclosed |
| US-6255483-B1 | USEFUL AS LIGHT STABILIZERS FOR TEXTILE FIBER MATERIALS AND SUNSCREENS FOR HUMAN SKIN | CIBA SPECIALTY CHEMICALS CORPORATION | 2001-07-03 | — | — | US | disclosed |
| EP-0815089-A1 | BIPHENYL-SUBSTITUTED TRIAZINES AS LIGHT STABILIZER | Ciba SC Holding AG (CH) | 1998-01-07 | — | — | EP | disclosed |
| WO-1996028431-A1 | BIPHENYL-SUBSTITUTED TRIAZINES AS LIGHT STABILIZER | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1996-09-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11161813-B2 | Sterically hindered amines | H1-0, F12, H1-2 | NOX1 84/4885GAA 3191/4885MAPT 1749/4885 |
| US-20010039341-A1 | Biphenyl-Substituted Triazines | TYR, CYP1B1, NFE2L2 | NOX1 344/4885GAA 3171/4885MAPT 111/4885 |
| US-20200123107-A1 | STERICALLY HINDERED AMINES | H1-0, F12, H1-2 | NOX1 84/4885GAA 3191/4885MAPT 1749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.